The Multiple Sclerosis Society of Canada has reserved $1 million to be used for a clinical trial of a controversial treatment for the disorder if preliminary results of studies suggest such a trial is warranted.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.